Clalit Research Institute, Clalit Health Services, Ramat Gan, Israel.
Department of Epidemiology, School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Cancer. 2023 Jun 1;129(11):1763-1776. doi: 10.1002/cncr.34740. Epub 2023 Mar 17.
There is a paucity of information on health outcomes of adolescent and young adult (AYA) cancer survivors living outside North America and Europe. This study compared outcomes in AYA cancer survivors in Israel with individuals without cancer and similar demographics and access to health care, and to AYA cancer survivors living in the United States.
This study included 12,674 2-year survivors of AYA (aged 15-39 years) cancer diagnosed between 2000 and 2018 at Clalit Health Services (CHS) in Israel. CHS participants without cancer (N = 50,696) were matched 4:1 to survivors on age, sex, ethnicity, and membership duration. Poisson regression was used to determine incidence rate ratios (IRRs) for chronic conditions. The US Kaiser Permanente Southern California AYA cohort (N = 6778) was used to estimate weighted (age, sex) standardized incidence ratios (SIRs) for CHS survivors.
CHS AYA cancer survivors were more likely to have any chronic condition (IRR, 1.6 95% CI, 1.5-1.7), compared with participants without cancer. Survivors had an increased risk across nearly all conditions examined, with especially elevated risks for osteoporosis (IRR, 4.7; 95% CI, 4.1-5.5) and cardiomyopathy (IRR, 4.2 95% CI, 3.4-5.3). Compared with the Kaiser Permanente Southern California cohort, CHS survivors had an overall lower (SIR, 0.68; 95% CI, 0.65-0.72) incidence of developing any health condition, with noticeably lower incidence of hyperlipidemia (SIR, 0.7; 95% CI, 0.64-0.75).
AYA cancer survivors in Israel are at increased risk for developing chronic conditions compared with individuals without cancer, but the overall incidence was lower than in US survivors. These findings may allow for refinement of surveillance recommendations for AYA survivors, taking into consideration regional differences in sociodemographic characteristics and cancer care.
The burden of chronic conditions was consistently greater in Israeli adolescent and young adult cancer survivors compared with individuals without cancer, with clear differences in risk of specific conditions by cancer diagnosis. However, the overall incidence of chronic conditions in Israeli survivors was generally lower than in US survivors.
在北美和欧洲以外的青少年和年轻成人(AYA)癌症幸存者的健康结果方面,信息十分匮乏。本研究比较了以色列 AYA 癌症幸存者的结果,以及没有癌症且具有相似人口统计学特征和获得医疗保健的个体,以及生活在美国的 AYA 癌症幸存者的结果。
本研究纳入了 2000 年至 2018 年期间在以色列克利夫健康服务中心(CHS)诊断为 AYA(年龄 15-39 岁)癌症的 12674 例 2 年幸存者。CHS 无癌症参与者(N=50696)按年龄、性别、种族和会员期限与幸存者进行 4:1 匹配。使用泊松回归确定慢性疾病的发病率比(IRR)。美国凯撒永久南加州 AYA 队列(N=6778)用于估计 CHS 幸存者的加权(年龄、性别)标准化发病率比(SIR)。
与无癌症参与者相比,CHS AYA 癌症幸存者更有可能患有任何慢性疾病(IRR,1.6;95%CI,1.5-1.7)。幸存者几乎所有检查的疾病风险均增加,尤其是骨质疏松症(IRR,4.7;95%CI,4.1-5.5)和心肌病(IRR,4.2;95%CI,3.4-5.3)的风险增加。与凯撒永久南加州队列相比,CHS 幸存者发生任何健康状况的总体发生率较低(SIR,0.68;95%CI,0.65-0.72),血脂异常的发生率明显较低(SIR,0.7;95%CI,0.64-0.75)。
与无癌症个体相比,以色列 AYA 癌症幸存者发生慢性疾病的风险增加,但总体发病率低于美国幸存者。这些发现可以为 AYA 幸存者的监测建议提供依据,考虑到社会人口特征和癌症护理方面的区域差异。